Nexavar
Active Ingredient(s): Sorafenib TosylateFDA Approved: * December 20, 2005
Pharm Company: * BAYER PHARMS
Category: Cancer
Sorafenib (co-developed and co-marketed by Bayer and Onyx Pharmaceuticals as Nexavar),[1] is a kinase inhibitor drug approved for the treatment of primary kidney cancer (advanced renal cell carcinoma), advanced primary liver cancer (hepatocellular carcinoma), FLT3-ITD positive AML and radioactive iodine resistant advanced thyroid carcinoma. Contents 1 Mechanism of action 2 Medical uses 2.1 Kidney cancer 2.2 Liver cancer 2.3 Thyroid cancer 2.4 Desmoid tumors 3 Adverse effe... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.9 Discussions
Dosage List
Popular Topics
I would like to know if anyone is on this med and if it working and how are the side effects? Thank you very much ## Hel...
2 REPLIESHi. My 18 year old son has AML with flt-3 gene mutation. He has been using a low dose of Nexavar 200mg 2x/day for 2 week...
I talked to my oncologist today and he is going to put me on nexavar I was curious as to the percentage of rate of succe...
2 REPLIEScancer drug...
Do you know any one who uses Nexavar lon term for liver cancer? My husband was diagnosed with HCC, and he has been on Ne...